Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens

Background: Quantitation of human herpesvirus-6 (HHV-6) DNA in clinical specimens is important for the diagnosis and management of HHV-6-associated infection and reactivation in immunocompromised patients, particularly transplant recipients. Methods: The analytical performance of the Altona RealStar...

Full description

Bibliographic Details
Main Authors: Jordan Mah, ChunHong Huang, Malaya K. Sahoo, Benjamin A. Pinsky
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Practical Laboratory Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551723000239
_version_ 1797692797820600320
author Jordan Mah
ChunHong Huang
Malaya K. Sahoo
Benjamin A. Pinsky
author_facet Jordan Mah
ChunHong Huang
Malaya K. Sahoo
Benjamin A. Pinsky
author_sort Jordan Mah
collection DOAJ
description Background: Quantitation of human herpesvirus-6 (HHV-6) DNA in clinical specimens is important for the diagnosis and management of HHV-6-associated infection and reactivation in immunocompromised patients, particularly transplant recipients. Methods: The analytical performance of the Altona RealStar ASR HHV-6 qPCR on the semi-automated AltoStar AM16 system was assessed using HHV-6 reference material in plasma and cerebral spinal fluid (CSF). Qualitative and quantitative agreement was determined using 123 clinical EDTA plasma specimens tested using a laboratory-developed HHV-6 qPCR. Results: The 95% Lower Limit of Detection was 20 IU/mL [95% confidence interval (CI): 10 to 29] in plasma and 78 IU/mL (95% CI: 55 to 146) in CSF. The assay was linear from 7.0 to 2.0 log10 IU/mL in both matrices. Overall agreement of the RealStar ASR HHV-6 qPCR on the AltoStar AM16 with a laboratory-developed test was 95.9% (95% CI: 90.8 to 98.7). Passing-Bablok analysis of specimens quantifiable by both methods and at levels >1000 copies/mL revealed a regression line of Y = 1.00*X–0.20, with neither systematic (95% CI Y-intercept: −0.66 to 0.26) nor proportional (95% CI slope: 0.89 to 1.10) bias compared to the reference. Conclusions: The RealStar ASR HHV-6 qPCR on the AltoStar AM16 provides accurate quantitation for clinical monitoring of HHV-6 in immunocompromised hosts.
first_indexed 2024-03-12T02:33:44Z
format Article
id doaj.art-5ff84fa8a3ff4c46a3c43323892ecf40
institution Directory Open Access Journal
issn 2352-5517
language English
last_indexed 2024-03-12T02:33:44Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series Practical Laboratory Medicine
spelling doaj.art-5ff84fa8a3ff4c46a3c43323892ecf402023-09-05T04:16:00ZengElsevierPractical Laboratory Medicine2352-55172023-08-0136e00329Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimensJordan Mah0ChunHong Huang1Malaya K. Sahoo2Benjamin A. Pinsky3Department of Pathology, Stanford University School of Medicine, Stanford, CA, USADepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USADepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USADepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA; Corresponding author. 3375 Hillview, Room 2913 Palo Alto, CA 94304, USA.Background: Quantitation of human herpesvirus-6 (HHV-6) DNA in clinical specimens is important for the diagnosis and management of HHV-6-associated infection and reactivation in immunocompromised patients, particularly transplant recipients. Methods: The analytical performance of the Altona RealStar ASR HHV-6 qPCR on the semi-automated AltoStar AM16 system was assessed using HHV-6 reference material in plasma and cerebral spinal fluid (CSF). Qualitative and quantitative agreement was determined using 123 clinical EDTA plasma specimens tested using a laboratory-developed HHV-6 qPCR. Results: The 95% Lower Limit of Detection was 20 IU/mL [95% confidence interval (CI): 10 to 29] in plasma and 78 IU/mL (95% CI: 55 to 146) in CSF. The assay was linear from 7.0 to 2.0 log10 IU/mL in both matrices. Overall agreement of the RealStar ASR HHV-6 qPCR on the AltoStar AM16 with a laboratory-developed test was 95.9% (95% CI: 90.8 to 98.7). Passing-Bablok analysis of specimens quantifiable by both methods and at levels >1000 copies/mL revealed a regression line of Y = 1.00*X–0.20, with neither systematic (95% CI Y-intercept: −0.66 to 0.26) nor proportional (95% CI slope: 0.89 to 1.10) bias compared to the reference. Conclusions: The RealStar ASR HHV-6 qPCR on the AltoStar AM16 provides accurate quantitation for clinical monitoring of HHV-6 in immunocompromised hosts.http://www.sciencedirect.com/science/article/pii/S2352551723000239
spellingShingle Jordan Mah
ChunHong Huang
Malaya K. Sahoo
Benjamin A. Pinsky
Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens
Practical Laboratory Medicine
title Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens
title_full Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens
title_fullStr Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens
title_full_unstemmed Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens
title_short Evaluation of an automated system for the quantitation of human Herpesvirus-6 DNA from clinical specimens
title_sort evaluation of an automated system for the quantitation of human herpesvirus 6 dna from clinical specimens
url http://www.sciencedirect.com/science/article/pii/S2352551723000239
work_keys_str_mv AT jordanmah evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens
AT chunhonghuang evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens
AT malayaksahoo evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens
AT benjaminapinsky evaluationofanautomatedsystemforthequantitationofhumanherpesvirus6dnafromclinicalspecimens